Abstract: Apparatus and method for treating medical implants are provided. The apparatus may include a vessel having a treatment chamber with an inside surface, an outside surface, an entrance, a plurality of fluid passages passing from the outside surface to the inside surface, and a compressible fluid supply line coupled to at least one of the fluid passages. In this embodiment, passages may be positioned and sized to create a buffer zone of compressible fluids between the inside surface of the treatment chamber and a medical implant placed therein. The method may include placing a first medical implant into a treatment chamber having inside surfaces, retarding the first medical implant from contacting the inside surfaces of the treatment chamber by injecting compressible fluid into the treatment chamber, injecting a therapeutic into the treatment chamber, and removing the first medical implant.

Abstract: A separator plate for a fuel cell is provided including a first support element and a series of second support elements extending from a first surface of the plate. A series of apertures are disposed between the first support element and the series of second support elements for communicating a reactant gas therethrough for delivery to a flow field of the separator plate.

Abstract: A parallel tube heat exchanger receiving two-phase refrigerant flow from a common manifold is provided with an eductor nozzle in one end of the manifold so as to cause the flow of refrigerant to pass along one leg of the manifold and down another leg thereof so as to reenter the upstream end of the first leg by way of a crossover tube. In this way, the two-phase refrigerant flow to the parallel tubes is more uniformly distributed. In one embodiment of the invention, the manifold is a unitary tube with a centrally disposed, longitudinally extending partition to define two longitudinally extending chambers that fluidly communicate by gaps at the ends of the central partition.

Abstract: A multi-step method of manufacturing a medical device containing therapeutic agents that results in a lower maximum error in the amount of therapeutic agents actually disposed thereon and that allows for differential drug release kinetics along the length of the medical device.

Abstract: Apparatus and method for treating medical implants are provided. The apparatus may include a vessel having a treatment chamber with an inside surface, an outside surface, an entrance, a plurality of fluid passages passing from the outside surface to the inside surface, and a compressible fluid supply line coupled to at least one of the fluid passages. In this embodiment, passages may be positioned and sized to create a buffer zone of compressible fluids between the inside surface of the treatment chamber and a medical implant placed therein. The method may include placing a first medical implant into a treatment chamber having inside surfaces, retarding the first medical implant from contacting the inside surfaces of the treatment chamber by injecting compressible fluid into the treatment chamber, injecting a therapeutic into the treatment chamber, and removing the first medical implant.

Abstract: A wireless control system for lighting or the like has a central processor that receives commands from keypads and other control devices, and sends commands to dimmers and other controlled devices. The central processor also receives status reports from the dimmers and sends updates to the keypads, in order to ensure that displays on the keypads are up to date.

Abstract: A method of diagnosing insulin resistance and related disorders is provided. Additionally, methods of treating mammals with insulin resistance and related disorders is provided. The methods employ antagonists to an insulin receptor tyrosine kinase inhibitor protein.

Abstract: A method of diagnosing insulin resistance and related disorders is provided. Additionally, methods of treating animals with insulin resistance and related disorders if provided. The methods employ antagonists to an insulin receptor tyrosine kinase inhibitor protein.

Abstract: Growth hormone receptor and growth hormone binding protein are purified enabling amino acid sequence and DNA isolates coding for growth hormone receptor and growth hormone binding protein and methods of obtaining such DNA are provided, together with expression systems for recombinant production of growth hormone receptor and growth hormone binding protein. Therapeutically useful forms of the growth hormone receptor and growth hormone binding protein and anti-receptor antibodies are described.

Abstract: Growth hormone receptor and growth hormone binding protein are purified enabling amino acid sequence and DNA isolates coding for growth hormone receptor and growth hormone binding protein and methods of obtaining such DNA are provided, together with expression systems for recombinant production of growth hormone receptor and growth hormone binding protein. Therapeutically useful forms of the growth hormone receptor and growth hormone binding protein and anti-receptor antibodies are described.

Abstract: The activity of growth-associated receptors is modulated in vivo in a controlled and reproducible fashion by immunizing animals against target growth-associated receptors. This is accomplished by the use of immunogens predetermined to induce primarily agonist or antagonist responses. The immunogens include anti-ligand antibodies and receptor derivatives.